|
Daily Medical Update
Tachyarrhythmias
Sunday, September 06, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Critical pathways in cardiology (2025) - Systematic Review and Meta-Analysis
Key Findings
- Across 3 randomized trials involving 587 patients with ischemic cardiomyopathy and ICDs, catheter ablation and antiarrhythmic drugs showed no significant difference in all-cause mortality, cardiovascular mortality, or ventricular-tachycardia storm.
- No significant reduction or increase was observed for appropriate ICD shocks or secondary outcomes, including inappropriate shocks, antitachycardia pacing, heart-failure hospitalization, stroke or transient ischemic attack, and myocardial infarction.
📋 Practice Implication: This synthesis supports individualized ablation referral rather than assuming catheter ablation is universally superior as first-line therapy for ischemic VT.
|
The western journal of emergency medicine (2025) - Network Meta-Analysis
Key Findings
- In 19 trials involving 2,545 adults, the modified Valsalva maneuver was more than twice as effective versus standard Valsalva for single-attempt sinus-rhythm conversion (RR 2.71, 95% CrI 2.26-3.31).
- Modified Valsalva reduced rescue intravenous drug use versus standard Valsalva (RR 0.64) and carotid-sinus massage (RR 0.59), while no maneuver differed in multiple-attempt success or adverse events.
📋 Practice Implication: Use the modified Valsalva maneuver as the preferred initial bedside strategy for hemodynamically stable SVT before rescue pharmacotherapy.
|
Journal of cardiovascular electrophysiology (2025) - Systematic Review and Meta-Analysis
Key Findings
- Across 6 studies involving 963 patients with electrical storm, catheter ablation reduced electrical-storm recurrence by 71% versus medical therapy (OR 0.29, 95% CI 0.15-0.53; P < .001).
- Catheter ablation was also associated with lower ventricular-arrhythmia recurrence and in-hospital mortality, as well as better long-term survival.
📋 Practice Implication: Consider early electrophysiology consultation for catheter ablation when ventricular electrical storm persists despite initial medical stabilization.
|
Medicine (2026) - Systematic Review and Meta-Analysis
Key Findings
- In 8 studies of patients with structural heart disease receiving ICD therapy, catheter ablation reduced recurrent VT (OR 0.42, 95% CI 0.27-0.64; P < .001) and cardiac hospitalization (OR 0.55, 95% CI 0.34-0.89; P = .015).
- Inappropriate ICD shocks were reduced (OR 0.36, 95% CI 0.20-0.66; P < .001), whereas all-cause mortality, cardiovascular mortality, appropriate shocks, antitachycardia pacing, and VT or electrical storm did not differ significantly.
📋 Practice Implication: For ICD-treated structural heart disease with recurrent VT or inappropriate shocks, adjunctive ablation may reduce arrhythmia burden and hospitalization without an established mortality benefit.
|
Heart rhythm (2026) - Systematic Review and Meta-Analysis
Key Findings
- Among 355 patients from 8 observational studies, major arrhythmic events occurred in 46.4% during a mean pooled follow-up of 3.8 years after acute myocarditis with sustained ventricular arrhythmia.
- No significant increase or reduction in follow-up major arrhythmic-event risk was consistently associated with demographic or comorbidity factors, ICD implantation before discharge, reduced LVEF, or the presence or location of late gadolinium enhancement.
📋 Practice Implication: Patients with this high-risk myocarditis presentation need structured long-term rhythm follow-up, because current individual predictors do not reliably identify who will recur.
|
|
💡
Summary
The highest-significance evidence suggests that catheter ablation can reduce ventricular tachycardia or electrical-storm recurrence in selected structural heart disease populations, although one randomized-trial meta-analysis found comparable efficacy and safety to antiarrhythmic drugs. For stable supraventricular tachycardia, the modified Valsalva maneuver produced the best rapid conversion and reduced rescue intravenous drug use without more adverse events. Acute myocarditis complicated by sustained ventricular arrhythmia carried substantial long-term major arrhythmic risk, with no consistent predictors identified.
|
|